Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta Mosca

Showing results (321-330 of 377) with videos related to

Pageof 38
Sort By:
The Lancet. Rheumatology|November 1, 2024
Identification of red flags for IgG4-related disease: an international European Reference Network for Rare Connective Tissue Diseases frameworkEmanuel Della-Torre, Rosaria Talarico, Jose Ballarin, et al.
Annals of the Rheumatic Diseases|April 18, 2014
Treat-to-target in systemic lupus erythematosus: recommendations from an international task forceRonald F van Vollenhoven, Marta Mosca, George Bertsias, et al.
Rheumatology (Oxford, England)|December 29, 2020
Serum IgG2 antibody multicomposition in systemic lupus erythematosus and lupus nephritis (Part 1): cross-sectional analysisMaurizio Bruschi, Gabriella Moroni, Renato Alberto Sinico, et al.
Lupus Science & Medicine|September 22, 2016
Off-label use of rituximab for systemic lupus erythematosus in EuropeMonica Rydén-Aulin, Dimitrios Boumpas, Irene Bultink, et al.
Rheumatology (Oxford, England)|December 22, 2020
Serum IgG2 antibody multi-composition in systemic lupus erythematosus and in lupus nephritis (Part 2): prospective studyMaurizio Bruschi, Gabriella Moroni, Renato Alberto Sinico, et al.
Autoimmunity Reviews|December 21, 2018
Disease activity assessment of rheumatic diseases during pregnancy: a comprehensive review of indices used in clinical studiesLaura Andreoli, Maria Chiara Gerardi, Melissa Fernandes, et al.
Lupus Science & Medicine|October 25, 2022
Health information use by patients with systemic lupus erythematosus (SLE) pre and during the COVID-19 pandemicFrancesca S Cardwell, Susan J Elliott, Ricky Chin, et al.
RMD Open|March 20, 2019
Idiopathic inflammatory myopathies: state of the art on clinical practice guidelines [corrected]Alain Meyer, Carlo Alberto Scirè, Rosaria Talarico, et al.
Orphanet Journal of Rare Diseases|March 11, 2025
Pregnancy-related issues in rare and low-prevalence diseases: results of ERN transversal working group on pregnancy and family planning surveyDina Zucchi, Diana Marinello, Chiara Tani, et al.
Seminars in Arthritis and Rheumatism|January 28, 2024
OMERACT 2023 Systemic Lupus Erythematosus Special Interest Group: Winnowing and Binning Preliminary Candidate Domains for the Core Outcome SetWils Nielsen, Vibeke Strand, Lee S Simon, et al.
Pageof 38

Showing results (321-330 of 377) with videos related to

Sort By:
Pageof 38
The Lancet. Rheumatology|November 1, 2024
Identification of red flags for IgG4-related disease: an international European Reference Network for Rare Connective Tissue Diseases frameworkEmanuel Della-Torre, Rosaria Talarico, Jose Ballarin, et al.
Annals of the Rheumatic Diseases|April 18, 2014
Treat-to-target in systemic lupus erythematosus: recommendations from an international task forceRonald F van Vollenhoven, Marta Mosca, George Bertsias, et al.
Rheumatology (Oxford, England)|December 29, 2020
Serum IgG2 antibody multicomposition in systemic lupus erythematosus and lupus nephritis (Part 1): cross-sectional analysisMaurizio Bruschi, Gabriella Moroni, Renato Alberto Sinico, et al.
Lupus Science & Medicine|September 22, 2016
Off-label use of rituximab for systemic lupus erythematosus in EuropeMonica Rydén-Aulin, Dimitrios Boumpas, Irene Bultink, et al.
Rheumatology (Oxford, England)|December 22, 2020
Serum IgG2 antibody multi-composition in systemic lupus erythematosus and in lupus nephritis (Part 2): prospective studyMaurizio Bruschi, Gabriella Moroni, Renato Alberto Sinico, et al.
Autoimmunity Reviews|December 21, 2018
Disease activity assessment of rheumatic diseases during pregnancy: a comprehensive review of indices used in clinical studiesLaura Andreoli, Maria Chiara Gerardi, Melissa Fernandes, et al.
Lupus Science & Medicine|October 25, 2022
Health information use by patients with systemic lupus erythematosus (SLE) pre and during the COVID-19 pandemicFrancesca S Cardwell, Susan J Elliott, Ricky Chin, et al.
RMD Open|March 20, 2019
Idiopathic inflammatory myopathies: state of the art on clinical practice guidelines [corrected]Alain Meyer, Carlo Alberto Scirè, Rosaria Talarico, et al.
Orphanet Journal of Rare Diseases|March 11, 2025
Pregnancy-related issues in rare and low-prevalence diseases: results of ERN transversal working group on pregnancy and family planning surveyDina Zucchi, Diana Marinello, Chiara Tani, et al.
Seminars in Arthritis and Rheumatism|January 28, 2024
OMERACT 2023 Systemic Lupus Erythematosus Special Interest Group: Winnowing and Binning Preliminary Candidate Domains for the Core Outcome SetWils Nielsen, Vibeke Strand, Lee S Simon, et al.
Pageof 38